Kv3 Modulator AUT00201 can promote recovery post CNS trauma such as stroke via enhanced activity of parvalbumin interneurones

Causal mutations in the genes encoding Kv3.1 and Kv3.2 have been increasingly linked to debilitating CNS diseases such as epilepsy, developmental encephalopathies, intellectual disability and autism

Kv3 Modulator AUT00206 offers potential as a precision medicine approach for the treatment of progressive myoclonic epilepsy (EPM7)